PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: DISEASE OVERVIEW PART 06: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 07: PIPELINE PART 08: MARKET SEGMENTATION BY PRODUCT Market segmentation by product Comparison by product Topical - Market size and forecast 2018-2023 Dressings - Market size and forecast 2018-2023 Oral - Market size and forecast 2018-2023 Market opportunity by product PART 09: CUSTOMER LANDSCAPE PART 10: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL PART 11: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison Asia - Market size and forecast 2018-2023 North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 12: DECISION FRAMEWORK PART 13: DRIVERS AND CHALLENGES Market drivers Market challenges PART 14: MARKET TRENDS PART 15: VENDOR LANDSCAPE Overview Landscape disruption Competitive scenario PART 16: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors 3M Acelity LP Inc. ConvaTec Group Plc Mölnlycke Health Care AB Smith & Nephew Plc PART 17: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 18: EXPLORE TECHNAVIO   Exhibit 01: Global pharmaceuticals market Exhibit 02: Segments of global pharmaceuticals market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Factors driving global radiodermatitis treatment market 2019-2023 Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Types of radiodermatitis Exhibit 11: Epidemiology statistics of cancer in the US Exhibit 12: Five forces analysis 2018 Exhibit 13: Five forces analysis 2023 Exhibit 14: Bargaining power of buyers Exhibit 15: Bargaining power of suppliers Exhibit 16: Threat of new entrants Exhibit 17: Threat of substitutes Exhibit 18: Threat of rivalry Exhibit 19: Market condition - Five forces 2018 Exhibit 20: Pipeline landscape Exhibit 21: Some of the drugs investigated for radiodermatitis Exhibit 22: Product - Market share 2018-2023 (%) Exhibit 23: Comparison by product Exhibit 24: Topical - Market size and forecast 2018-2023 ($ millions) Exhibit 25: Topical - Year-over-year growth 2019-2023 (%) Exhibit 26: Dressings - Market size and forecast 2018-2023 ($ millions) Exhibit 27: Dressings - Year-over-year growth 2019-2023 (%) Exhibit 28: Oral - Market size and forecast 2018-2023 ($ millions) Exhibit 29: Oral - Year-over-year growth 2019-2023 (%) Exhibit 30: Market opportunity by product Exhibit 31: Customer landscape Exhibit 32: Market share by distribution channel, 2018 Exhibit 33: Market share by geography 2018-2023 (%) Exhibit 34: Geographic comparison Exhibit 35: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 36: Incidence rate of lung cancer Exhibit 37: Asia - Year-over-year growth 2019-2023 (%) Exhibit 38: Top 3 countries in Asia Exhibit 39: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 40: Key industry trends in North America Exhibit 41: North America - Year-over-year growth 2019-2023 (%) Exhibit 42: Top 3 countries in North America Exhibit 43: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 44: Incidence rate of cancer in Germany, 2012 Exhibit 45: Projected incidence rate of cancer in Germany, 2030 Exhibit 46: Europe - Year-over-year growth 2019-2023 (%) Exhibit 47: Top 3 countries in Europe Exhibit 48: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 49: Facts about cancer in Australia Exhibit 50: ROW - Year-over-year growth 2019-2023 (%) Exhibit 51: Top 3 countries in ROW Exhibit 52: Key leading countries Exhibit 53: Market opportunity Exhibit 54: Cancer prevalence in US in 2015 Exhibit 55: Cancer prevalence in England in 2016 Exhibit 56: Types of external beam radiation therapy Exhibit 57: Impact of drivers and challenges Exhibit 58: CDC statistics for obesity and diabetes Exhibit 59: Vendor landscape Exhibit 60: Landscape disruption Exhibit 61: Vendors covered Exhibit 62: Vendor classification Exhibit 63: Market positioning of vendors Exhibit 64: M - Vendor overview Exhibit 65: M - Business segments Exhibit 66: M - Organizational developments Exhibit 67: M - Geographic focus Exhibit 68: M - Segment focus Exhibit 69: M - Key offerings Exhibit 70: M - Key customers Exhibit 71: Acelity LP Inc. - Vendor overview Exhibit 72: Acelity LP Inc. - Organizational developments Exhibit 73: Acelity LP Inc. - Key offerings Exhibit 74: Acelity LP Inc. - Key customers Exhibit 75: ConvaTec Group Plc - Vendor overview Exhibit 76: ConvaTec Group Plc - Product segments Exhibit 77: ConvaTec Group Plc - Organizational developments Exhibit 78: ConvaTec Group Plc - Geographic focus Exhibit 79: ConvaTec Group Plc - Segment focus Exhibit 80: ConvaTec Group Plc - Key offerings Exhibit 81: ConvaTec Group Plc - Key customers Exhibit 82: Mölnlycke Health Care AB - Vendor overview Exhibit 83: Mölnlycke Health Care AB - Product segments Exhibit 84: Mölnlycke Health Care AB - Organizational developments Exhibit 85: Mölnlycke Health Care AB - Geographic focus Exhibit 86: Mölnlycke Health Care AB - Segment focus Exhibit 87: Mölnlycke Health Care AB - Key offerings Exhibit 88: Mölnlycke Health Care AB - Key customers Exhibit 89: Smith & Nephew Plc - Vendor overview Exhibit 90: Smith & Nephew Plc - Business segments Exhibit 91: Smith & Nephew Plc - Organizational developments Exhibit 92: Smith & Nephew Plc - Geographic focus Exhibit 93: Smith & Nephew Plc - Segment focus Exhibit 94: Smith & Nephew Plc - Key offerings Exhibit 95: Smith & Nephew Plc - Key customers Exhibit 96: Validation techniques employed for market sizing Exhibit 97: Definition of market positioning of vendors

3M Acelity LP Inc. ConvaTec Group Plc Mölnlycke Health Care AB Smith & Nephew Plc.